<?xml version="1.0" encoding="UTF-8"?><ns2:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:ns2="http://www.sec.gov/edgar/ownership">
    <ns2:headerData>
        <ns2:submissionType>144</ns2:submissionType>
        <ns2:filerInfo>
            <ns2:filer>
                <ns2:filerCredentials>
                    <ns2:cik>0001615062</ns2:cik>
                    <ns2:ccc>XXXXXXXX</ns2:ccc>
                </ns2:filerCredentials>
            </ns2:filer>
            <ns2:liveTestFlag>LIVE</ns2:liveTestFlag>



        </ns2:filerInfo>
    </ns2:headerData>
    <ns2:formData>
        <ns2:issuerInfo>
            <ns2:issuerCik>0001428336</ns2:issuerCik>
            <ns2:issuerName>HealthEquity, Inc.</ns2:issuerName>
            <ns2:secFileNumber>001-36568</ns2:secFileNumber>
            <ns2:issuerAddress>
                <com:street1>15 West Scenic Pointe Drive</com:street1>
                <com:street2>Suite 100</com:street2>
                <com:city>Draper</com:city>
                <com:stateOrCountry>UT</com:stateOrCountry>
                <com:zipCode>84020</com:zipCode>
            </ns2:issuerAddress>
            <ns2:issuerContactPhone>1-866-855-8908</ns2:issuerContactPhone>
            <ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Jon Kessler</ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <ns2:relationshipsToIssuer>
                <ns2:relationshipToIssuer>Director</ns2:relationshipToIssuer>
            </ns2:relationshipsToIssuer>
        </ns2:issuerInfo>
        <ns2:securitiesInformation>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:brokerOrMarketmakerDetails>
                <ns2:name>Goldman Sachs &amp; Co. LLC</ns2:name>
                <ns2:address>
                    <com:street1>200 West Street</com:street1>
                    <com:city>New York</com:city>
                    <com:stateOrCountry>NY</com:stateOrCountry>
                    <com:zipCode>10282</com:zipCode>
                </ns2:address>
            </ns2:brokerOrMarketmakerDetails>
            <ns2:noOfUnitsSold>85000</ns2:noOfUnitsSold>
            <ns2:aggregateMarketValue>7031200</ns2:aggregateMarketValue>
            <ns2:noOfUnitsOutstanding>87010560</ns2:noOfUnitsOutstanding>
            <ns2:approxSaleDate>06/24/2024</ns2:approxSaleDate>
            <ns2:securitiesExchangeName>NASD</ns2:securitiesExchangeName>
        </ns2:securitiesInformation>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:acquiredDate>03/30/2022</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Performance Awards</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>12095</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>03/30/2022</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:acquiredDate>03/30/2022</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Performance Awards</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>2035</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>03/30/2022</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:acquiredDate>03/29/2023</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Performance Awards</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>45870</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>03/29/2023</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:acquiredDate>07/30/2019</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as a gift</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Jon Kessler</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>Y</ns2:isGiftTransaction>
            <ns2:donarAcquiredDate>07/30/2014</ns2:donarAcquiredDate>
            <ns2:amountOfSecuritiesAcquired>25000</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>12/08/2021</ns2:paymentDate>
            <ns2:natureOfPayment>None</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <ns2:remarks>The sales of shares set forth herein are made in connection with a selling plan dated 3/25/2024, that is intended to comply with Rule 10b5-1(c).

25,000 shares to be sold  by GKF,LLC
45,870 shares to be sold by Jon and Laura Joint. Shares were Acquired via Compensation - Performance Awards - Transmutation to Community Property
14,130 shares to be sold by Jon Kessler</ns2:remarks>
        <ns2:noticeSignature>
            <ns2:noticeDate>06/24/2024</ns2:noticeDate>
            <ns2:planAdoptionDates>
                <ns2:planAdoptionDate>03/25/2024</ns2:planAdoptionDate>
            </ns2:planAdoptionDates>
            <ns2:signature>Goldman Sachs &amp; Co. LLC on behalf of Jon Kessler</ns2:signature>
        </ns2:noticeSignature>
    </ns2:formData>
</ns2:edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 6225}]
144
0001615062
XXXXXXXX
LIVE
0001428336
HealthEquity, Inc.
001-36568
15 West Scenic Pointe Drive
Suite 100
Draper
UT
84020
1-866-855-8908
Jon Kessler
Director
Common Stock
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
85000
7031200
87010560
06/24/2024
NASD
Common Stock
03/30/2022
Acquired as compensation -- Performance Awards
Issuer
N
12095
03/30/2022
Compensation
Common Stock
03/30/2022
Acquired as compensation -- Performance Awards
Issuer
N
2035
03/30/2022
Compensation
Common Stock
03/29/2023
Acquired as compensation -- Performance Awards
Issuer
N
45870
03/29/2023
Compensation
Common Stock
07/30/2019
Acquired as a gift
Jon Kessler
Y
07/30/2014
25000
12/08/2021
None
Y
The sales of shares set forth herein are made in connection with a selling plan dated 3/25/2024, that is intended to comply with Rule 10b5-1(c).

25,000 shares to be sold  by GKF,LLC
45,870 shares to be sold by Jon and Laura Joint. Shares were Acquired via Compensation - Performance Awards - Transmutation to Community Property
14,130 shares to be sold by Jon Kessler
06/24/2024
03/25/2024
Goldman Sachs & Co. LLC on behalf of Jon Kessler